CD14 and intrahepatic cholangiocarcinoma: Moreover, neonates with DCC had significantly higher median values of CD19+ (12.8 vs. 10.1 percentage to total lymphocytes, p = 0.029) and CD14+/TLR (93.3 vs. 87.1 percentage to total lymphocytes, p = 0.025) and lower median values of CD3+/CD4+ (49.6 vs. 59.2 percentage to total lymphocytes, p = 0.034), compared to neonates with ICC at birth (Table 3).